CLINICAL_TRIALS
trial_result
· 2010-12-21
Clinical Trial Update: PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) [Phase 3]
Summary
A Phase 3 clinical trial of PegIntron for chronic hepatitis B in HBeAg-positive patients has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2010-12-21